Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.010
+0.040 (1.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Anixa Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
100.92M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seer, Inc. | 16.58M |
| Coya Therapeutics | 7.95M |
| Rani Therapeutics Holdings | 1.63M |
| Coeptis Therapeutics Holdings | 1.36M |
| NRx Pharmaceuticals | 1.23M |
| Inovio Pharmaceuticals | 65.34K |
| InflaRx | 34.44K |
| Fractyl Health | 3.00K |
ANIX News
- 6 days ago - Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting - PRNewsWire
- 14 days ago - Anixa Biosciences Transcript: Water Tower Research Insights Conference - Transcripts
- 19 days ago - Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 - PRNewsWire
- 21 days ago - Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 - PRNewsWire
- 22 days ago - Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs - PRNewsWire
- 27 days ago - Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing - PRNewsWire
- 4 weeks ago - Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer - PRNewsWire
- 6 weeks ago - Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast - PRNewsWire